Another product for adapt coming soon, page-25

From what I can gather a surgeon will trial a product like cardiocel then evaluate for around 3 months before deciding to use it. So on this assumption we should start to see some forward orders of larger numbers flowing in. Hopefully this info is included in the update we are getting soon on cardiocel. As for the vaccine. Well we know there is a T cell response, now we need to know which cells were stimulated. Most people haven't put a value on the vaccine and still see this level as a good entry. Get the right T cell response and you will start to see done money for the vaccine arrive. It's Fraser. And a 6 billion dollar market.